Cargando…
Inotropic support in cardiogenic shock: who leads the battle, milrinone or dobutamine?
Cardiovascular diseases remain the leading cause of death globally, with acute myocardial infarction being one of the most frequent. One of the complications that can occur after a myocardial infarction is cardiogenic shock. At present, the evidence on the use of inotropic agents for the management...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577832/ https://www.ncbi.nlm.nih.gov/pubmed/36268289 http://dx.doi.org/10.1016/j.amsu.2022.104763 |